Management of Lisinopril in Hypotensive Patients
Introduction to Lisinopril Management
- The American Heart Association recommends holding lisinopril when blood pressure is low due to the risk of hypotension, which could lead to decreased organ perfusion and adverse outcomes 1
- The European Society of Cardiology states that hypotension (systolic BP <90 mmHg or significantly below baseline) is a clear contraindication to ACE inhibitor administration 1, 2
Clinical Decision Making
- Assessing current blood pressure and symptoms is crucial, as a blood pressure of 100/66 mmHg is already at the lower end of the normal range, and administering lisinopril would likely cause further reduction in blood pressure 2
- The American College of Cardiology recommends considering the risks of administering lisinopril, including further BP reduction, inadequate organ perfusion, and risk of symptomatic hypotension, especially with lower baseline BP 1
- The decision to hold lisinopril should be based on the patient's current blood pressure and symptoms, with consideration of the risks and benefits of ACE inhibitor therapy 3
Special Patient Populations
- In patients with heart failure or post-MI status, the benefits of ACE inhibitor therapy must be weighed against the risks of hypotension, as stated by the American Heart Association 4
- For patients with heart failure, careful dose titration of lisinopril may be necessary after effective management of hypotension 4
Management After Holding Lisinopril
- The European Society of Cardiology recommends monitoring blood pressure frequently until it stabilizes, and assessing volume status to consider IV fluids if hypovolemia is contributing to hypotension 2, 5
- When blood pressure improves, consider restarting lisinopril at a lower dose, and evaluate for alternative causes of hypotension if blood pressure remains low despite holding antihypertensive medications 3, 5
Avoiding Common Pitfalls
- The American College of Cardiology advises against continuing ACE inhibitors despite hypotension, as it can lead to renal dysfunction, syncope, and inadequate organ perfusion, and recommends recognizing drug interactions and volume depletion as contributing factors to hypotension 2